Acquisition and licensing

[sumonasumonakha.t]

Pfizer's Weaknesses
Legal Issues: Pfizer has been constantly dragged to court and faced several lawsuits alleging illegal marketing practices. This has indeed resulted in losses for them as they are constantly facing these allegations;
Over-dependence on the US economy: Even for a multinational company, Pfizer has not leveled its prospects as the company still manages to remain dependent on the US market. A decline in the US market automatically means a decline in Pfizer’s gross profit. This over-dependence on one market could hamper its growth and expansion in other regions;
Patent renewals: Pfizer's constant need to renew patents can be time-consuming and expensive, and also creates a risk of counterfeit drugs, ultimately impacting sales and market share.
Pfizer capabilities
Development of new medicines: Pfizer may continue to invest in research and development to develop croatia phone number data new medicines and vaccines to address unmet medical needs;
diversification: Pfizer may explore diversification into other healthcare sectors, such as medical devices, diagnostics and healthcare services, to reduce its dependence on pharmaceutical products and expand its market reach;
Technological advances: Pfizer can invest in technological advances in drug development and manufacturing, such as artificial intelligence and robotics, which can reduce costs and increase efficiency;
Expanding into emerging markets: Pfizer can capitalize on the growth potential in emerging markets such as India, China and Brazil, where there is strong demand for pharmaceutical products and a growing middle class with greater purchasing power.
Pfizer Threats


Pfizer competitors